Clinical Trial Update: Effect of Abdominal Obesity on Lipoprotein Metabolism [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of abdominal obesity on lipoprotein metabolism has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Insulin Resistance
• Obesity

Snippet

Sponsor: The University of Western Australia | Conditions: Obesity, Dyslipidemia | Phase 3 | Status: COMPLETED